Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p3763 has 323 genes in the original annotation. Currently, there are 242 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
10006	ABI1	ABI-1 \| ABLBP4 \| E3B1 \| NAP1BP \| SSH3BP \| SSH3BP1	abl interactor 1	10p11.2
1316	KLF6	BCD1 \| CBA1 \| COPEB \| CPBP \| GBF \| PAC1 \| ST12 \| ZF9	Kruppel-like factor 6	10p15
8031	NCOA4	ARA70 \| ELE1 \| PTC3 \| RFG	nuclear receptor coactivator 4	10q11.2
5979	RET	CDHF12 \| CDHR16 \| HSCR1 \| MEN2A \| MEN2B \| MTC1 \| PTC \| RET-ELE1 \| RET51	ret proto-oncogene	10q11.2
80312	TET1	CXXC6 \| LCX \| MLL-TET1 \| TET1-MLL \| bA119F7.1	tet methylcytosine dioxygenase 1	10q21
23522	KAT6B	GTPTS \| MORF \| MOZ2 \| MYST4 \| ZC2HC6B \| qkf \| querkopf	lysine acetyltransferase 6B	10q22.2
657	BMPR1A	10q23del \| ACVRLK3 \| ALK3 \| CD292 \| SKR5	bone morphogenetic protein receptor type 1A	10q22.3
5728	PTEN	10q23del \| BZS \| CWS1 \| DEC \| GLM2 \| MHAM \| MMAC1 \| PTEN1 \| TEP1	phosphatase and tensin homolog	10q23.3
4791	NFKB2	CVID10 \| H2TF1 \| LYT-10 \| LYT10 \| NF-kB2 \| p100 \| p49/p100 \| p52	nuclear factor of kappa light polypeptide gene enhancer in B-cells 2	10q24
355	FAS	ALPS1A \| APO-1 \| APT1 \| CD95 \| FAS1 \| FASTM \| TNFRSF6	Fas cell surface death receptor	10q24.1
51684	SUFU	PRO1280 \| SUFUH \| SUFUXL	SUFU negative regulator of hedgehog signaling	10q24.32
2263	FGFR2	BBDS \| BEK \| BFR-1 \| CD332 \| CEK3 \| CFD1 \| ECT1 \| JWS \| K-SAM \| KGFR \| TK14 \| TK25	fibroblast growth factor receptor 2	10q26
1643	DDB2	DDBB \| UV-DDB2 \| XPE	damage specific DNA binding protein 2	11p11.2
2132	EXT2	SOTV \| SSMS	exostosin glycosyltransferase 2	11p12-p11
4005	LMO2	RBTN2 \| RBTNL1 \| RHOM2 \| TTG2	LIM domain only 2	11p13
7490	WT1	AWT1 \| EWS-WT1 \| GUD \| NPHS4 \| WAGR \| WIT-2 \| WT33	Wilms tumor 1	11p13
4004	LMO1	RBTN1 \| RHOM1 \| TTG1	LIM domain only 1	11p15
2188	FANCF	FAF	Fanconi anemia complementation group F	11p15
4928	NUP98	ADIR2 \| NUP196 \| NUP96	nucleoporin 98kDa	11p15.5
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
833	CARS	CARS1 \| CYSRS \| MGC:11246	cysteinyl-tRNA synthetase	11p15.5
10978	CLP1	HEAB \| hClp1	cleavage and polyadenylation factor I subunit 1	11q12
4221	MEN1	MEAI \| SCG2	menin 1	11q13
4926	NUMA1	NMP-22 \| NUMA	nuclear mitotic apparatus protein 1	11q13
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
84441	MAML2	MAM-3 \| MAM2 \| MAM3 \| MLL-MAML2	mastermind like transcriptional coactivator 2	11q21
330	BIRC3	AIP1 \| API2 \| CIAP2 \| HAIP1 \| HIAP1 \| MALT2 \| MIHC \| RNF49 \| c-IAP2	baculoviral IAP repeat containing 3	11q22
1662	DDX10	HRH-J8	DEAD-box helicase 10	11q22-q23
472	ATM	AT1 \| ATA \| ATC \| ATD \| ATDC \| ATE \| TEL1 \| TELO1	ATM serine/threonine kinase	11q22-q23
6392	SDHD	CBT1 \| CII-4 \| CWS3 \| PGL \| PGL1 \| QPs3 \| SDH4 \| cybS	succinate dehydrogenase complex subunit D	11q23
7704	ZBTB16	PLZF \| ZNF145	zinc finger and BTB domain containing 16	11q23.1
23365	ARHGEF12	LARG \| PRO2792	Rho guanine nucleotide exchange factor 12	11q23.3
1656	DDX6	HLR2 \| P54 \| RCK	DEAD-box helicase 6	11q23.3
867	CBL	C-CBL \| CBL2 \| FRA11B \| NSLL \| RNF55	Cbl proto-oncogene, E3 ubiquitin protein ligase	11q23.3
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
2120	ETV6	TEL \| TEL/ABL \| THC5	ETS variant 6	12p13
894	CCND2	KIAK0002 \| MPPH3	cyclin D2	12p13
23085	ERC1	Cast2 \| ELKS \| ERC-1 \| RAB6IP2	ELKS/RAB6-interacting/CAST family member 1	12p13.3
466	ATF1	EWS-ATF1 \| FUS/ATF-1 \| TREB36	activating transcription factor 1	12q13
1649	DDIT3	CEBPZ \| CHOP \| CHOP-10 \| CHOP10 \| GADD153	DNA damage inducible transcript 3	12q13.1-q13.2
3229	HOXC13	ECTD9 \| HOX3 \| HOX3G	homeobox C13	12q13.3
1019	CDK4	CMM3 \| PSK-J3	cyclin-dependent kinase 4	12q14
8091	HMGA2	BABL \| HMGI-C \| HMGIC \| LIPO \| STQTL9	high mobility group AT-hook 2	12q15
694	BTG1	-	B-cell translocation gene 1, anti-proliferative	12q22
5781	PTPN11	BPTP3 \| CFC \| JMML \| METCDS \| NS1 \| PTP-1D \| PTP2C \| SH-PTP2 \| SH-PTP3 \| SHP2	protein tyrosine phosphatase, non-receptor type 11	12q24
6927	HNF1A	HNF-1A \| HNF1 \| IDDM20 \| LFB1 \| MODY3 \| TCF-1 \| TCF1	HNF1 homeobox A	12q24.2
10186	LHFP	-	lipoma HMGIC fusion partner	13q12
675	BRCA2	BRCC2 \| BROVCA2 \| FACD \| FAD \| FAD1 \| FANCD \| FANCD1 \| GLM3 \| PNCA2 \| XRCC11	breast cancer 2	13q12.3
1045	CDX2	CDX-3 \| CDX2/AS \| CDX3	caudal type homeobox 2	13q12.3
2308	FOXO1	FKH1 \| FKHR \| FOXO1A	forkhead box O1	13q14.1
5925	RB1	OSRC \| PPP1R130 \| RB \| p105-Rb \| pRb \| pp110	retinoblastoma 1	13q14.2
57820	CCNB1IP1	C14orf18 \| HEI10	cyclin B1 interacting protein 1, E3 ubiquitin protein ligase	14q11.2
3895	KTN1	CG1 \| KNT \| MU-RMS-40.19	kinectin 1	14q22.1
51199	NIN	SCKL7	ninein	14q22.1
5890	RAD51B	R51H2 \| RAD51L1 \| REC2	RAD51 paralog B	14q23-q24.2
10243	GPHN	GEPH \| GPH \| GPHRYN \| HKPX1 \| MOCODC	gephyrin	14q23.3
7253	TSHR	CHNG1 \| LGR3 \| hTSHR-I	thyroid stimulating hormone receptor	14q31
9321	TRIP11	ACG1A \| CEV14 \| GMAP-210 \| GMAP210 \| TRIP-11 \| TRIP230	thyroid hormone receptor interactor 11	14q32.12
64919	BCL11B	ATL1 \| ATL1-alpha \| ATL1-beta \| ATL1-delta \| ATL1-gamma \| CTIP-2 \| CTIP2 \| RIT1 \| ZNF856B \| hRIT1-alpha	B-cell CLL/lymphoma 11B	14q32.2
3320	HSP90AA1	EL52 \| HEL-S-65p \| HSP86 \| HSP89A \| HSP90A \| HSP90N \| HSPC1 \| HSPCA \| HSPCAL1 \| HSPCAL4 \| HSPN \| Hsp89 \| Hsp90 \| LAP-2 \| LAP2	heat shock protein 90kDa alpha family class A member 1	14q32.33
701	BUB1B	BUB1beta \| BUBR1 \| Bub1A \| MAD3L \| MVA1 \| SSK1 \| hBUBR1	BUB1 mitotic checkpoint serine/threonine kinase B	15q15
5371	PML	MYL \| PP8675 \| RNF71 \| TRIM19	promyelocytic leukemia	15q22
4916	NTRK3	GP145-TrkC \| TRKC \| gp145(trkC)	neurotrophic tyrosine kinase, receptor, type 3	15q25
641	BLM	BS \| RECQ2 \| RECQL2 \| RECQL3	Bloom syndrome RecQ like helicase	15q26.1
50615	IL21R	CD360 \| NILR	interleukin 21 receptor	16p11
2521	FUS	ALS6 \| ETM4 \| FUS1 \| HNRNPP2 \| POMP75 \| TLS	FUS RNA binding protein	16p11.2
4261	CIITA	C2TA \| CIITAIV \| MHC2TA \| NLRA	class II, major histocompatibility complex, transactivator	16p13
608	TNFRSF17	BCM \| BCMA \| CD269 \| TNFRSF13A	tumor necrosis factor receptor superfamily member 17	16p13.1
4629	MYH11	AAT4 \| FAA4 \| SMHC \| SMMHC	myosin, heavy chain 11, smooth muscle	16p13.11
2072	ERCC4	ERCC11 \| FANCQ \| RAD1 \| XFEPS \| XPF	excision repair cross-complementation group 4	16p13.12
7249	TSC2	LAM \| PPP1R160 \| TSC4	tuberous sclerosis 2	16p13.3
1387	CREBBP	CBP \| KAT3A \| RSTS	CREB binding protein	16p13.3
1540	CYLD	BRSS \| CDMT \| CYLD1 \| CYLDI \| EAC \| MFT \| MFT1 \| SBS \| TEM \| USPL2	CYLD lysine 63 deubiquitinase	16q12.1
1009	CDH11	CAD11 \| CDHOB \| OB \| OSF-4	cadherin 11	16q21
4094	MAF	AYGRP \| CCA4 \| CTRCT21 \| c-MAF	v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog	16q22-q23
865	CBFB	PEBP2B	core-binding factor, beta subunit	16q22.1
863	CBFA2T3	ETO2 \| MTG16 \| MTGR2 \| ZMYND4	core-binding factor, runt domain, alpha subunit 2; translocated to, 3	16q24
654780	SFPQ	-	splicing factor proline/glutamine-rich	16q24.1
2175	FANCA	FA \| FA-H \| FA1 \| FAA \| FACA \| FAH \| FANCH	Fanconi anemia complementation group A	16q24.3
92521	SPECC1	CYTSB \| HCMOGT-1 \| HCMOGT1 \| NSP	sperm antigen with calponin homology and coiled-coil domains 1	17p11.2
201163	FLCN	BHD \| FLCL	folliculin	17p11.2
5187	PER1	PER \| RIGUI \| hPER	period circadian clock 1	17p13.1
8522	GAS7	MLL/GAS7	growth arrest specific 7	17p13.1
7157	TP53	BCC7 \| LFS1 \| P53 \| TRP53	tumor protein p53	17p13.1
9135	RABEP1	RAB5EP \| RABPT5	rabaptin, RAB GTPase binding effector protein 1	17p13.2
3927	LASP1	Lasp-1 \| MLN50	LIM and SH3 protein 1	17q11-q21.3
23512	SUZ12	CHET9 \| JJAZ1	SUZ12 polycomb repressive complex 2 subunit	17q11.2
4763	NF1	NFNS \| VRNF \| WSS	neurofibromin 1	17q11.2
2064	ERBB2	CD340 \| HER-2 \| HER-2/neu \| HER2 \| MLN 19 \| NEU \| NGL \| TKR1	erb-b2 receptor tyrosine kinase 2	17q12
672	BRCA1	BRCAI \| BRCC1 \| BROVCA1 \| FANCS \| IRIS \| PNCA4 \| PPP1R53 \| PSCP \| RNF53	breast cancer 1	17q21
5914	RARA	NR1B1 \| RAR	retinoic acid receptor alpha	17q21
4302	MLLT6	AF17	myeloid/lymphoid or mixed-lineage leukemia; translocated to, 6	17q21
124540	MSI2	MSI2H	musashi RNA binding protein 2	17q22
5573	PRKAR1A	ACRDYS1 \| ADOHR \| CAR \| CNC \| CNC1 \| PKR1 \| PPNAD1 \| PRKAR1 \| TSE1	protein kinase cAMP-dependent type I regulatory subunit alpha	17q24.2
10801	SEPT9	AF17q25 \| MSF \| MSF1 \| NAPB \| PNUTL4 \| SINT1 \| SeptD1	septin 9	17q25
79058	ASPSCR1	ASPCR1 \| ASPL \| ASPS \| RCC17 \| TUG \| UBXD9 \| UBXN9	alveolar soft part sarcoma chromosome region, candidate 1	17q25.3
57674	RNF213	ALO17 \| C17orf27 \| KIAA1618 \| MYMY2 \| MYSTR \| NET57	ring finger protein 213	17q25.3
10892	MALT1	IMD12 \| MLT \| MLT1 \| PCASP1	MALT1 paracaspase	18q21
4089	SMAD4	DPC4 \| JIP \| MADH4 \| MYHRS	SMAD family member 4	18q21.1
2531	KDSR	DHSR \| FVT1 \| SDR35C1	3-ketodihydrosphingosine reductase	18q21.3
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
8178	ELL	C19orf17 \| ELL1 \| MEN \| PPP1R68	elongation factor for RNA polymerase II	19p13.1
4066	LYL1	bHLHa18	lymphoblastic leukemia associated hematopoiesis regulator 1	19p13.2
6455	SH3GL1	CNSA1 \| EEN \| SH3D2B \| SH3P8	SH3-domain GRB2-like 1	19p13.3
6794	STK11	LKB1 \| PJS \| hLKB1	serine/threonine kinase 11	19p13.3
4298	MLLT1	ENL \| LTG19 \| YEATS1	myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1	19p13.3
6929	TCF3	E2A \| E47 \| ITF1 \| TCF-3 \| VDIR \| bHLHb21	transcription factor 3	19p13.3
1050	CEBPA	C/EBP-alpha \| CEBP	CCAAT/enhancer binding protein alpha	19q13.1
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
100124696	TEC	-	transient erythroblastopenia of childhood	19q13.2
2068	ERCC2	COFS2 \| EM9 \| TFIIH \| TTD \| TTD1 \| XPD	excision repair cross-complementation group 2	19q13.3
55422	ZNF331	RITA \| ZNF361 \| ZNF463	zinc finger protein 331	19q13.42
64783	RBM15	OTT \| OTT1 \| SPEN	RNA binding motif protein 15	1p13
51592	TRIM33	ECTO \| PTC7 \| RFG7 \| TF1G \| TIF1G \| TIF1GAMMA \| TIFGAMMA	tripartite motif containing 33	1p13.1
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
8915	BCL10	CARMEN \| CIPER \| CLAP \| IMD37 \| c-E10 \| mE10	B-cell CLL/lymphoma 10	1p22
6491	STIL	MCPH7 \| SIL	SCL/TAL1 interrupting locus	1p32
6886	TAL1	SCL \| TCL5 \| bHLHa17 \| tal-1	T-cell acute lymphocytic leukemia 1	1p32
6421	SFPQ	POMP100 \| PPP1R140 \| PSF	splicing factor proline/glutamine-rich	1p34.3
3932	LCK	IMD22 \| LSK \| YT16 \| p56lck \| pp58lck	LCK proto-oncogene, Src family tyrosine kinase	1p34.3
9967	THRAP3	TRAP150	thyroid hormone receptor associated protein 3	1p34.3
6390	SDHB	CWS2 \| IP \| PGL4 \| SDH \| SDH1 \| SDH2 \| SDHIP	succinate dehydrogenase complex iron sulfur subunit B	1p36.1-p35
5081	PAX7	HUP1 \| PAX7B \| RMS2	paired box 7	1p36.13
63976	PRDM16	CMD1LL \| LVNC8 \| MEL1 \| PFM13	PR domain 16	1p36.32
9659	PDE4DIP	CMYA2 \| MMGL	phosphodiesterase 4D interacting protein	1q12
405	ARNT	HIF-1-beta \| HIF-1beta \| HIF1-beta \| HIF1B \| HIF1BETA \| TANGO \| bHLHe2	aryl hydrocarbon receptor nuclear translocator	1q21
607	BCL9	LGS	B-cell CLL/lymphoma 9	1q21
4914	NTRK1	MTC \| TRK \| TRK1 \| TRKA \| Trk-A \| p140-TrkA	neurotrophic tyrosine kinase, receptor, type 1	1q21-q22
7170	TPM3	CAPM1 \| CFTD \| HEL-189 \| HEL-S-82p \| NEM1 \| OK/SW-cl.5 \| TM-5 \| TM3 \| TM30 \| TM30nm \| TM5 \| TPMsk3 \| TRK \| hscp30	tropomyosin 3	1q21.2
5087	PBX1	-	pre-B-cell leukemia homeobox 1	1q23
5396	PRRX1	AGOTC \| PHOX1 \| PMX1 \| PRX-1 \| PRX1	paired related homeobox 1	1q24
7175	TPR	-	translocated promoter region, nuclear basket protein	1q25
27	ABL2	ABLL \| ARG	ABL proto-oncogene 2, non-receptor tyrosine kinase	1q25.2
2271	FH	FMRD \| HLRCC \| LRCC \| MCL \| MCUL1	fumarate hydratase	1q42.1
9935	MAFB	KRML \| MCTO	v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B	20q12
7150	TOP1	TOPI	topoisomerase (DNA) I	20q12-q13.1
2778	GNAS	AHO \| C20orf45 \| GNAS1 \| GPSA \| GSA \| GSP \| NESP \| POH \| SCG6 \| SgVI	GNAS complex locus	20q13.3
10215	OLIG2	BHLHB1 \| OLIGO2 \| PRKCBP2 \| RACK17 \| bHLHe19	oligodendrocyte lineage transcription factor 2	21q22.11
2078	ERG	erg-3 \| p55	v-ets avian erythroblastosis virus E26 oncogene homolog	21q22.3
7113	TMPRSS2	PP9284 \| PRSS10	transmembrane protease, serine 2	21q22.3
861	RUNX1	AML1 \| AML1-EVI-1 \| AMLCR1 \| CBF2alpha \| CBFA2 \| EVI-1 \| PEBP2aB \| PEBP2alpha	runt related transcription factor 1	21q22.3
8218	CLTCL1	CHC22 \| CLH22 \| CLTCL \| CLTD	clathrin heavy chain like 1	22q11.21
5413	SEPT5	CDCREL \| CDCREL-1 \| CDCREL1 \| H5 \| HCDCREL-1 \| PNUTL1	septin 5	22q11.21
613	BCR	ALL \| BCR1 \| CML \| D22S11 \| D22S662 \| PHL	breakpoint cluster region	22q11.23
11200	CHEK2	CDS1 \| CHK2 \| HuCds1 \| LFS2 \| PP1425 \| RAD53 \| hCds1	checkpoint kinase 2	22q12.1
2130	EWSR1	EWS \| EWS-FLI1 \| bK984G1.4	EWS RNA binding protein 1	22q12.2
23598	PATZ1	MAZR \| PATZ \| RIAZ \| ZBTB19 \| ZNF278 \| ZSG \| dJ400N23	POZ/BTB and AT hook containing zinc finger 1	22q12.2
5155	PDGFB	IBGC5 \| PDGF-2 \| PDGF2 \| SIS \| SSV \| c-sis	platelet derived growth factor subunit B	22q13.1
4627	MYH9	BDPLT6 \| DFNA17 \| EPSTS \| FTNS \| MHA \| NMHC-II-A \| NMMHC-IIA \| NMMHCA	myosin, heavy chain 9, non-muscle	22q13.1
2033	EP300	KAT3B \| RSTS2 \| p300	E1A binding protein p300	22q13.2
5966	REL	C-Rel	v-rel avian reticuloendotheliosis viral oncogene homolog	2p13-p12
2956	MSH6	GTBP \| GTMBP \| HNPCC5 \| HSAP \| p160	mutS homolog 6	2p16
53335	BCL11A	BCL11A-L \| BCL11A-S \| BCL11A-XL \| BCL11a-M \| CTIP1 \| EVI9 \| HBFQTL5 \| ZNF856	B-cell CLL/lymphoma 11A	2p16.1
238	ALK	CD246 \| NBLST3	anaplastic lymphoma receptor tyrosine kinase	2p23
4613	MYCN	MODED \| N-myc \| NMYC \| ODED \| bHLHe37	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	2p24.3
3899	AFF3	LAF4 \| MLLT2-like	AF4/FMR2 family member 3	2q11.2-q12
150465	TTL	-	tubulin tyrosine ligase	2q13
3237	HOXD11	HOX4 \| HOX4F	homeobox D11	2q31.1
3239	HOXD13	BDE \| BDSD \| HOX4I \| SPD	homeobox D13	2q31.1
5378	PMS1	HNPCC3 \| MLH2 \| PMSL1 \| hPMS1	PMS1 homolog 1, mismatch repair system component	2q31.1
5077	PAX3	CDHS \| HUP2 \| WS1 \| WS3	paired box 3	2q35
54738	FEV	HSRNAFEV \| PET-1	FEV, ETS transcription factor	2q36
51517	NCKIPSD	AF3P21 \| DIP \| DIP1 \| ORF1 \| SPIN90 \| VIP54 \| WASLBP \| WISH	NCK interacting protein with SH3 domain	3p21
1499	CTNNB1	CTNNB \| MRD19 \| armadillo	catenin beta 1	3p21
4292	MLH1	COCA2 \| FCC2 \| HNPCC \| HNPCC2 \| hMLH1	mutL homolog 1	3p21.3
5468	PPARG	CIMT1 \| GLM1 \| NR1C3 \| PPARG1 \| PPARG2 \| PPARgamma	peroxisome proliferator activated receptor gamma	3p25
7428	VHL	HRCA1 \| RCA1 \| VHL1 \| pVHL	von Hippel-Lindau tumor suppressor	3p25.3
10342	TFG	HMSNP \| SPG57 \| TF6 \| TRKT3	TRK-fused gene	3q12.2
7555	CNBP	CNBP1 \| DM2 \| PROMM \| RNF163 \| ZCCHC22 \| ZNF9	CCHC-type zinc finger, nucleic acid binding protein	3q21
6184	RPN1	OST1 \| RBPH1	ribophorin I	3q21.3
8833	GMPS	-	guanine monophosphate synthase	3q24
4291	MLF1	-	myeloid leukemia factor 1	3q25.1
2122	MECOM	AML1-EVI-1 \| EVI1 \| MDS1 \| MDS1-EVI1 \| PRDM3 \| RUSAT2	MDS1 and EVI1 complex locus	3q26.2
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
604	BCL6	BCL5 \| BCL6A \| LAZ3 \| ZBTB27 \| ZNF51	B-cell CLL/lymphoma 6	3q27
1974	EIF4A2	BM-010 \| DDX2B \| EIF4A \| EIF4F \| eIF-4A-II \| eIF4A-II	eukaryotic translation initiation factor 4A2	3q28
4026	LPP	-	LIM domain containing preferred translocation partner in lipoma	3q28
7037	TFRC	CD71 \| IMD46 \| T9 \| TFR \| TFR1 \| TR \| TRFR \| p90	transferrin receptor	3q29
7006	TEC	PSCTK4	tec protein tyrosine kinase	4p12
8929	PHOX2B	NBLST2 \| NBPhox \| PMX2B	paired like homeobox 2b	4p12
2261	FGFR3	ACH \| CD333 \| CEK2 \| HSFGFR3EX \| JTK4	fibroblast growth factor receptor 3	4p16.3
7468	WHSC1	MMSET \| NSD2 \| REIIBP \| TRX5 \| WHS	Wolf-Hirschhorn syndrome candidate 1	4p16.3
26511	CHIC2	BTL	cysteine rich hydrophobic domain 2	4q11
5156	PDGFRA	CD140A \| GAS9 \| PDGFR-2 \| PDGFR2 \| RHEPDGFRA	platelet derived growth factor receptor alpha	4q12
3815	KIT	C-Kit \| CD117 \| PBT \| SCFR	KIT proto-oncogene receptor tyrosine kinase	4q12
4299	AFF1	AF4 \| MLLT2 \| PBM1	AF4/FMR2 family member 1	4q21
3558	IL2	IL-2 \| TCGF \| lymphokine	interleukin 2	4q26-q27
3977	LIFR	CD118 \| LIF-R \| SJS2 \| STWS \| SWS	leukemia inhibitory factor receptor alpha	5p13-p12
324	APC	BTPS2 \| DP2 \| DP2.5 \| DP3 \| GS \| PPP1R46	adenomatous polyposis coli	5q21-q22
23092	ARHGAP26	GRAF \| GRAF1 \| OPHN1L \| OPHN1L1	Rho GTPase activating protein 26	5q31
3702	ITK	EMT \| LPFS1 \| LYK \| PSCTK2	IL2 inducible T-cell kinase	5q31-q32
23305	ACSL6	ACS2 \| FACL6 \| LACS 6 \| LACS2 \| LACS5	acyl-CoA synthetase long-chain family member 6	5q31.1
5159	PDGFRB	CD140B \| IBGC4 \| IMF1 \| JTK12 \| KOGS \| PDGFR \| PDGFR-1 \| PDGFR1 \| PENTT	platelet derived growth factor receptor beta	5q33.1
64324	NSD1	ARA267 \| KMT3B \| SOTOS \| SOTOS1 \| STO	nuclear receptor binding SET domain protein 1	5q35
4869	NPM1	B23 \| NPM	nucleophosmin (nucleolar phosphoprotein B23, numatrin)	5q35.1
30012	TLX3	HOX11L2 \| RNX	T-cell leukemia homeobox 3	5q35.1
3326	HSP90AB1	D6S182 \| HSP84 \| HSP90B \| HSPC2 \| HSPCB	heat shock protein 90kDa alpha family class B member 1	6p12
3159	HMGA1	HMG-R \| HMGA1A \| HMGIY	high mobility group AT-hook 1	6p21
896	CCND3	-	cyclin D3	6p21
7942	TFEB	ALPHATFEB \| BHLHE35 \| TCFEB	transcription factor EB	6p21
5292	PIM1	PIM	Pim-1 proto-oncogene, serine/threonine kinase	6p21.2
8294	HIST1H4I	H4/m \| H4FM \| H4M	histone cluster 1, H4i	6p21.33
7913	DEK	D6S231E	DEK proto-oncogene	6p22.3
3662	IRF4	LSIRF \| MUM1 \| NF-EM5 \| SHEP8	interferon regulatory factor 4	6p25.3
2309	FOXO3	AF6q21 \| FKHRL1 \| FKHRL1P2 \| FOXO2 \| FOXO3A	forkhead box O3	6q21
1956	EGFR	ERBB \| ERBB1 \| HER1 \| NISBD2 \| PIG61 \| mENA	epidermal growth factor receptor	7p12
10320	IKZF1	Hs.54452 \| IK1 \| IKAROS \| LYF1 \| LyF-1 \| PPP1R92 \| PRO0758 \| ZNFN1A1	IKAROS family zinc finger 1	7p12.2
3205	HOXA9	ABD-B \| HOX1 \| HOX1.7 \| HOX1G	homeobox A9	7p15.2
3207	HOXA11	HOX1 \| HOX1I \| RUSAT1	homeobox A11	7p15.2
3209	HOXA13	HOX1 \| HOX1J	homeobox A13	7p15.2
221895	JAZF1	TIP27 \| ZNF802	JAZF zinc finger 1	7p15.2-p15.1
2115	ETV1	ER81	ETS variant 1	7p21.3
51119	SBDS	CGI-97 \| SDS \| SWDS	SBDS ribosome assembly guanine nucleotide exchange factor	7q11.21
3092	HIP1	HIP-I \| ILWEQ \| SHON \| SHONbeta \| SHONgamma	huntingtin interacting protein 1	7q11.23
1021	CDK6	MCPH12 \| PLSTIRE	cyclin-dependent kinase 6	7q21-q22
6608	SMO	FZD11 \| Gx \| SMOH	smoothened, frizzled class receptor	7q32.3
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
3110	MNX1	HB9 \| HLXB9 \| HOXHB9 \| SCRA1	motor neuron and pancreas homeobox 1	7q36
54904	WHSC1L1	NSD3 \| WHISTLE \| pp14328	Wolf-Hirschhorn syndrome candidate 1-like 1	8p11.2
2260	FGFR1	BFGFR \| CD331 \| CEK \| FGFBR \| FGFR-1 \| FLG \| FLT-2 \| FLT2 \| HBGFR \| HH2 \| HRTFDS \| KAL2 \| N-SAM \| OGD \| bFGF-R-1	fibroblast growth factor receptor 1	8p11.23-p11.22
7486	WRN	RECQ3 \| RECQL2 \| RECQL3	Werner syndrome RecQ like helicase	8p12
5108	PCM1	PTC4 \| RET/PCM-1	pericentriolar material 1	8p22-p21.3
6917	TCEA1	GTF2S \| SII \| TCEA \| TF2S \| TFIIS	transcription elongation factor A1	8q11.2
4683	NBN	AT-V1 \| AT-V2 \| ATV \| NBS \| NBS1 \| P95	nibrin	8q21
862	RUNX1T1	AML1-MTG8 \| AML1T1 \| CBFA2T1 \| CDR \| ETO \| MTG8 \| ZMYND2	runt related transcription factor 1; translocated to, 1 (cyclin D related)	8q22
4609	MYC	MRTL \| MYCC \| bHLHe39 \| c-Myc	v-myc avian myelocytomatosis viral oncogene homolog	8q24.21
2189	FANCG	FAG \| XRCC9	Fanconi anemia complementation group G	9p13
5079	PAX5	ALL3 \| BSAP	paired box 5	9p13
1029	CDKN2A	ARF \| CDK4I \| CDKN2 \| CMM2 \| INK4 \| INK4A \| MLM \| MTS-1 \| MTS1 \| P14 \| P14ARF \| P16 \| P16-INK4A \| P16INK4 \| P16INK4A \| P19 \| P19ARF \| TP16	cyclin-dependent kinase inhibitor 2A	9p21
4300	MLLT3	AF9 \| YEATS3	myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3	9p22
11168	PSIP1	DFS70 \| LEDGF \| PAIP \| PSIP2 \| p52 \| p75	PC4 and SFRS1 interacting protein 1	9p22.3
3717	JAK2	JTK10 \| THCYT3	Janus kinase 2	9p24
8013	NR4A3	CHN \| CSMF \| MINOR \| NOR1 \| TEC	nuclear receptor subfamily 4 group A member 3	9q22
6850	SYK	p72-Syk	spleen tyrosine kinase	9q22
2176	FANCC	FA3 \| FAC \| FACC	Fanconi anemia complementation group C	9q22.3
7507	XPA	XP1 \| XPAC	xeroderma pigmentosum, complementation group A	9q22.3
4958	OMD	OSAD \| SLRR2C	osteomodulin	9q22.31
6887	TAL2	-	T-cell acute lymphocytic leukemia 2	9q32
11064	CNTRL	CEP1 \| CEP110 \| FAN \| bA165P4.1	centriolin	9q33.2
8021	NUP214	CAIN \| CAN	nucleoporin 214kDa	9q34.1
25	ABL1	ABL \| JTK7 \| bcr/abl \| c-ABL \| c-ABL1 \| p150 \| v-abl	ABL proto-oncogene 1, non-receptor tyrosine kinase	9q34.1
4851	NOTCH1	AOS5 \| AOVD1 \| TAN1 \| hN1	notch 1	9q34.3